期刊文献+

酪酸梭菌与婴儿双歧杆菌对炎症性肠病小鼠肠道sIgA的影响 被引量:1

The effect of Clostridium butyricum and Bifidobacterium infantis on slgA in the intestine of IBD mice
原文传递
导出
摘要 目的建立三硝基苯磺酸(trinitro-benzene-sulfonic acid,TNBS)诱导的小鼠炎症性肠病(inflammatory bowel disease,IBD)模型,探讨肠道分泌型免疫球蛋白(secretory immunoglobulin A,sIgA)含量的变化与小鼠IBD发病的相互关系。研究酪酸梭菌(Clostridium butyricum,CB)、婴儿双歧杆菌(Bifidobacterium infantis,BB)分别或联合后对炎症状态下肠道sIgA的影响。方法采用简单随机法将小鼠分成5组:WT组、TNBS组、CB组、BB组和CB+BB组,每组10只;2周后观察小鼠的一般状态和体重变化,处死小鼠收集结肠组织;进行HE染色,观察各组小鼠结肠炎症的情况;应用ELISA法检测肠液中的sIgA浓度;应用免疫组化法和Western blot法对结肠组织的sIgA进行定位和定量研究。结果TNBS组肠道炎症改变较WT组、CB组、BB组和CB+BB组明显;在肠绒毛固有层中、肠腺腺腔内以及肠腺之间,都有sIgA的存在;TNBS组小鼠肠液和结肠组织中sIgA浓度水平均明显低于WT组(P均〈0.01);CB、BB组小鼠肠液和结肠组织sIgA表达水平明显高于TNBS组(P均〈0.01),CB和BB两组之间比较差异无统计学意义(P均〉0.05) ;CB+BB组小鼠肠液和结肠组织sIgA表达水平较CB组、BB组升高(P均〈0.01)。结论sIgA含量的变化与IBD的发生有关。CB和BB均能上调sIgA水平,改善IBD的肠道炎症反应,并且两菌联合比各自单独应用显示出更强的上调作用。 Objective To establish the inflammatory bowel disease model of mice by Trinitro-benzene- sulfonic acid( TNBS ). To investigate the correlation between the IBD and SIgA level and the effect of Clostridi- um butyricum,Bifidobacterium infantis single or combined on slgA expression. Methods BABL/c mice were randomly divided into. WT group, TNBS group, CB group, BB group and CB + BB group. After 2 weeks, the general situation and weight change of mice was evaluated. Then the mice were sacrificed to collect colon tissue. The inflammation of each group was observed by HE staining. The expression of slgA were respectively located and measured by irnmunohistochemistry and Western blotting. Results TNBS group showed more pathological changes in the colon than the WT group, CB group, BB group and CB + BB group;the expressions of slgA in co- lon were mainly located in intestinal lumen and lamina propria of intestinal villus; the level of slgA in colon and tissue decreased in the TNBS group compared with WT group( P 〈 0.01 ; P 〈 0. 01 ) ; the level of slgA in colon and tissue increased in the CB group and BB group compared with TNBS group(P 〈0. 01 ;P 〈0. 01 ;P 〈0. 01; P 〈 0. 01 ). There is no significant difference between CB group and BB group( P 〉 0. 05 ). The level of slgA in colon and tissue increased in the CB +BB group compared with CB group or BB group(P 〈0.01 ;P 〈0. 01 ). Conclusion The change of slgA content is related to the occurrence of IBD. CB and BB can both promote slgA production in IBD mice and reduce the inflammatory reaction. The combination of the two probiotics shows stronger effect than single one.
作者 王瑰娜 毛志芹 Wang Guina;Mao Zhiqin(Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China)
出处 《国际儿科学杂志》 2018年第4期311-314,F0003,共5页 International Journal of Pediatrics
基金 沈阳市科技计划项目(F13-220-9-41)
关键词 分泌型免疫球蛋白A 炎症性肠病 酪酸梭菌 婴儿双歧杆菌 小鼠 slgA Inflammatory bowel disease Clostridium butyricum Bifidobacterium infantis Mice
  • 相关文献

参考文献2

二级参考文献15

  • 1Hai-Mei Zhao,Xiao-Ying Huang,Zhi-Qin Zuo,Qi-Hong Pan,Mei-Ying Ao,Feng Zhou,Hong-Ning Liu,Zhi-Yong Liu,Duan-Yong Liu.Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice[J].World Journal of Gastroenterology,2013,19(5):742-749. 被引量:15
  • 2Kavitha Subramaniam,James D’Rozario,Paul Pavli.Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: A review[J]. J Gastroenterol Hepatol . 2012 (1)
  • 3Ana Izcue,Sophie Hue,Sofia Buonocore,Carolina V. Arancibia-Cárcamo,Philip P. Ahern,Yoichiro Iwakura,Kevin J. Maloy,Fiona Powrie.Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis[J]. Immunity . 2008 (4)
  • 4Mehmet Coskun,Mohammad Salem,Jannie Pedersen,Ole Haagen Nielsen.Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease[J].Pharmacological Research.2013
  • 5William J. Sandborn,Brian G. Feagan,Colleen Marano,Hongyan Zhang,Richard Strauss,Jewel Johanns,Omoniyi J. Adedokun,Cynthia Guzzo,Jean-Frederic Colombel,Walter Reinisch,Peter R. Gibson,Judith Collins,Gunnar J?rnerot,Paul Rutgeerts.Subcutaneous Golimumab Maintains Clinical Response in Patients with Moderate-To-Severe Ulcerative Colitis[J].Gastroenterology.2013
  • 6William J. Sandborn,Brian G. Feagan,Colleen Marano,Hongyan Zhang,Richard Strauss,Jewel Johanns,Omoniyi J. Adedokun,Cynthia Guzzo,Jean-Frederic Colombel,Walter Reinisch,Peter R. Gibson,Judith Collins,Gunnar J?rnerot,Toshifumi Hibi,Paul Rutgeerts.Subcutaneous Golimumab Induces Clinical Response and Remission in Patients with Moderate-To-Severe Ulcerative Colitis[J].Gastroenterology.2013
  • 7David Laharie,Arnaud Bourreille,Julien Branche,Matthieu Allez,Yoram Bouhnik,Jerome Filippi,Frank Zerbib,Guillaume Savoye,Maria Nachury,Jacques Moreau,Jean-Charles Delchier,Jacques Cosnes,Elena Ricart,Olivier Dewit,Antonio Lopez-Sanroman,Jean-Louis Dupas,Franck Carbonnel,Gilles Bommelaer,Benoit Coffin,Xavier Roblin,Gert Van Assche,Maria Esteve,Martti F?rkkil?,Javier P Gisbert,Philippe Marteau,Stephane Nahon,Martine de Vos,Denis Franchimont,Jean-Yves Mary,Jean-Frederic Colombel,Marc Lémann.Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial[J].The Lancet.2012(9857)
  • 8Hideyuki Yoshida,Akihiro Kimura,Tomohiro Fukaya,Takashi Sekiya,Rimpei Morita,Takashi Shichita,Hiromasa Inoue,Akihiko Yoshimura.Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation[J].Biochemical and Biophysical Research Communications.2012(2)
  • 9Hiu Kiu,Sandra E. Nicholson.Biology and significance of the JAK/STAT signalling pathways[J].Growth Factors.2012(2)
  • 10Eric R. Fedyk,Tim Wyant,Li‐Li Yang,Vilmos Csizmadia,Kristine Burke,Hua Yang,Vivek J. Kadambi.Exclusive antagonism of the α<sub>4</sub>β<sub>7</sub> integrin by vedolizumab confirms the gut‐selectivity of this pathway in primates[J].Inflamm Bowel Dis.2012(11)

共引文献36

同被引文献18

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部